ARTICLE | Company News
Intas Pharmaceuticals sales and marketing update
May 4, 2015 7:00 AM UTC
Intas launched Intacept, a biosimilar of autoimmune Enbrel entanercept, in India. Intas says that Intracept cuts the cost of treatment “to about half” compared to Enbrel from Amgen Inc. (NASDAQ:AMGN...